Xylem Inc.
XYL | NYSE
$96.86
+$4.46 (+4.83%)
Nov 2, 2026, 2:54 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 9.04B | 8.56B | 7.36B | 5.52B | 5.2B | 4.88B |
Cost of Revenue | 5.56B | 5.35B | 4.65B | 3.44B | 3.22B | 3.05B |
Gross Profit | 3.48B | 3.21B | 2.72B | 2.08B | 1.98B | 1.83B |
Operating Income | 1.22B | 1.01B | 652M | 622M | 585M | 367M |
Interest Income | n/a | 28M | 28M | 16M | 7M | 7M |
Pretax Income | 1.18B | 1.09B | 635M | 440M | 511M | 285M |
Net Income | 957M | 890M | 609M | 355M | 427M | 254M |
Selling & General & Admin | 1.92B | 1.91B | 1.76B | 1.37B | 1.18B | 1.14B |
Research & Development | 226M | 230M | 232M | 206M | 204M | 187M |
Other Expenses | 103M | 62M | 76M | -111M | 7M | 133M |
Operating Expenses | 2.25B | 2.2B | 2.07B | 1.46B | 1.39B | 1.46B |
Interest Expense | 29M | 44M | 49M | 50M | 76M | 77M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 7.81B | 7.55B | 6.71B | 4.9B | 4.61B | 4.51B |
Income Tax Expense | 231M | 197M | 26M | 85M | 84M | 31M |
Shares Outstanding (Basic) | 243.4M | 242.6M | 216.98M | 180.22M | 180.25M | 180.12M |
Shares Outstanding (Diluted) | 244M | 243.5M | 218.18M | 180.98M | 181.53M | 181.1M |
EPS (Basic) | 3.93 | 3.67 | 2.81 | 1.97 | 2.37 | 1.41 |
EPS (Diluted) | 3.92 | 3.65 | 2.79 | 1.96 | 2.35 | 1.40 |
EBITDA | 1.79B | 1.69B | 1.12B | 726M | 832M | 613M |
EBIT | 1.21B | 1.13B | 684M | 490M | 587M | 362M |
Depreciation & Amortization | 575M | 562M | 436M | 236M | 245M | 251M |
Add to Watchlist
Select watchlists to add or remove XYL